IUHSA
MRNA icon

Itau Unibanco Holding S.A.’s Moderna MRNA Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Sell
2,245
-5
-0.2% -$259 ﹤0.01% 230
2026
Q1 		$114K Buy
2,250
+76
+3% +$3.55K ﹤0.01% 200
2025
Q4 		$64.1K Buy
2,174
+1,179
+118% +$32K ﹤0.01% 213
2025
Q3 		$25.7K Hold
995
– – ﹤0.01% 316
2025
Q2 		$27.5K Sell
995
-18
-2% -$474 ﹤0.01% 316
2025
Q1 		$29K Hold
1,013
– – ﹤0.01% 333
2024
Q4 		$42.1K Buy
1,013
+343
+51% +$16.4K ﹤0.01% 273
2024
Q3 		$44.8K Buy
670
+41
+7% +$3.76K ﹤0.01% 196
2024
Q2 		$74.7K Buy
+629
New +$79.6K ﹤0.01% 158
2024
Q1 		– Sell
-1,478
Closed -$147K – 275
2023
Q4 		$147K Buy
1,478
+419
+40% +$35.2K ﹤0.01% 163
2023
Q3 		$109K Sell
1,059
-326
-24% -$36.4K ﹤0.01% 188
2023
Q2 		$168K Buy
1,385
+677
+96% +$90.3K 0.01% 188
2023
Q1 		$109K Sell
708
-985
-58% -$162K 0.01% 229
2022
Q4 		$303K Sell
1,693
-193
-10% -$31.6K 0.01% 178
2022
Q3 		$223K Sell
1,886
-276
-13% -$41.9K 0.01% 212
2022
Q2 		$309K Buy
2,162
+694
+47% +$99.2K 0.01% 187
2022
Q1 		$253K Buy
1,468
+508
+53% +$85.5K 0.01% 203
2021
Q4 		$242K Buy
960
+162
+20% +$47.4K 0.01% 159
2021
Q3 		$307K Buy
798
+218
+38% +$80.4K 0.02% 135
2021
Q2 		$136K Buy
+580
New +$104K 0.01% 131

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Itau Unibanco Holding S.A.'s MRNA Position: Q2 2026 in Review

Itau Unibanco Holding S.A. reduced its Moderna (MRNA) stake by 0.22% in Q2 2026, selling an estimated $259 and leaving 2,245 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Itau Unibanco Holding S.A. first reported a position in MRNA in Q2 2021 and has held it in 20 quarters since. The position peaked at $309K in Q2 2022. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Itau Unibanco Holding S.A. held 2,245 shares of Moderna worth $157K as of Q2 2026.
  • Itau Unibanco Holding S.A. sold 5 Moderna shares in Q2 2026, an estimated $259.
  • Moderna made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #230 holding.
  • Itau Unibanco Holding S.A. first reported a position in Moderna in Q2 2021 and has held it in 20 quarters since.
  • Itau Unibanco Holding S.A.'s Moderna position peaked at $309K in Q2 2022.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.